Matthias Guckenberger

Professor Matthias Guckenberger is Director of the Department of Radio-Oncology at the University Hospital Zurich (USZ) and Professor of Radiation Oncology at the University of Zurich. He also serves as Deputy Head of the Uro-Oncology Center and Director of CCCZ Outreach and Education at the Comprehensive Cancer Center Zurich. His leadership extends to board positions including the Comprehensive Cancer Center Zurich and the USZ Foundation.

• Since 2014: Professor and Full Professor of Radiation Oncology, University of Zurich
• Since 2014: Director of the Department of Radio-Oncology, University Hospital Zurich
• 2017-2021: Vice Dean for Preclinical Studies, University of Zurich
• 2012-2014: Deputy Director of Radiation Oncology, University Hospital Würzburg, Germany
• Education: Human Medicine Studies (1997-2003), University of Würzburg

Professor Guckenberger's research focuses on advanced radiation therapy techniques with particular expertise in treating lung cancer, prostate cancer, and oligometastatic disease. His work emphasizes precision radiation delivery through stereotactic body radiotherapy, cranial radiosurgery, and MRI-guided adaptive radiotherapy. He has pioneered multimodal therapeutic approaches that combine radiation with other cancer treatments to improve patient outcomes.

His extensive publication record demonstrates leadership in developing clinical practice guidelines for stereotactic radiotherapy across multiple cancer types. The research trends show a strong focus on standardizing treatment protocols for oligometastatic disease, bone metastases, brain metastases, and primary tumors including renal cell carcinoma and hepatocellular carcinoma. His work bridges clinical practice with technological innovation in radiation oncology.

• 12th DEGRO Conference: Siemens Poster Prize
• 27th ESTRO Meeting: ESTRO Accuray Award
• 15th DEGRO Conference: Hermann-Holthusen Prize
• DEGRO Conference: Koester Prize
• SAMW Award "Interprofessionality"
• USZ Q Award
• 37th ESTRO Meeting: Honorary Physicist Award

As President-elect of the European Society for Therapeutic Radiation Oncology (ESTRO) and active member of numerous scientific boards including the EORTC Radiation Oncology Scientific Committee, Professor Guckenberger shapes international radiation oncology standards. His leadership in major clinical trials and guideline development has significantly influenced cancer treatment protocols worldwide. The Department of Radio-Oncology under his direction maintains strong collaborations with international research consortia focused on advancing stereotactic radiotherapy techniques and applications.